The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.
How Is The Market Size Of The Technetium-99m Market Expected To Change Between 2026 And 2030?
The technetium-99m market size has observed significant growth in recent years. It is projected to expand from $4.75 billion in 2025 to $4.99 billion in 2026, registering a compound annual growth rate (CAGR) of 5.1%. The expansion seen in the past can be attributed to factors such as the limited availability of radiopharmaceuticals, an increasing prevalence of cardiovascular diseases, the development of nuclear medicine infrastructure, government healthcare initiatives, and technological advancements in imaging modalities.
The technetium-99m market is anticipated to experience consistent expansion over the upcoming years. By 2030, this market is projected to reach $6.01 billion, demonstrating a compound annual growth rate (CAGR) of 4.8%. This projected growth is driven by several factors, including a higher demand for accurate diagnostics, the broadening of hospital and imaging center infrastructures, the creation of new Tc-99m radiopharmaceuticals, the incorporation of AI into nuclear imaging, and a greater emphasis on early disease identification. Key trends anticipated during this period involve a wider embrace of SPECT imaging, an increase in cardiac and oncology diagnostic procedures, a preference for short half-life radiopharmaceuticals, the expansion of centralized radiopharmacy operations, and improved regulatory adherence and safety measures.
Download the Free Sample Report to Explore Key Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=25920&type=smp
Which Major Factors Are Driving The Expansion Of The Technetium-99m Market?
The technetium-99m market is anticipated to grow in the future due to the increasing demand for diagnostic imaging procedures. Diagnostic imaging procedures are medical methods used to create visual representations of the body’s internal structures, aiding doctors in diagnosing and sometimes guiding treatments for various health conditions. The rising demand for these procedures stems from the growing prevalence of chronic diseases that necessitate early and precise diagnosis. Technetium-99m assists diagnostic imaging by allowing doctors to visualize the function of organs and tissues with high precision, leveraging its radioactive properties to generate detailed images in nuclear medicine scans. For instance, in November 2023, data from the National Health Service (NHS) England, a UK-based government department, indicated that 45.0 million imaging tests were performed in England in the year leading up to March 2023. This figure represents a 2.2% increase from the 44.0 million tests conducted in the previous year. Consequently, the increasing demand for diagnostic imaging procedures is driving the expansion of the technetium-99m market.
How Is The Technetium-99m Market Structured Across Different Segments?
The technetium-99m market covered in this report is segmented –
1) By Product Type: Radiopharmaceuticals, Diagnostic Kits, Generators
2) By Formulation Type: Liquid, Solid, Freeze-Dried
3) By Application: Single Photon Emission Computed Tomography (SPECT) Imaging, Oncology, Cardiology, Neurology, Other Applications
4) By End-User: Hospitals, Diagnostic Imaging Centers, Research Laboratories, Specialized Clinics, Other End-Users
Subsegments:
1) By Radiopharmaceuticals: Sestamibi, Tetrofosmin, Sulfur Colloid, MAA (Macroaggregated Albumin), DTPA (Diethylenetriaminepentaacetic Acid)
2) By Diagnostic Kits: Cardiac Imaging Kits, Bone Imaging Kits, Renal Imaging Kits, Hepatobiliary Imaging Kits, Pulmonary Imaging Kits
3) By Generators: Hospital-Based Generators, Centralized Radiopharmacy Generators
Which Trends Are Shaping The Future Of The Technetium-99m Market?
Leading firms in the technetium-99m market are concentrating on creating novel solutions, including sophisticated radiopharmaceutical imaging agents, to improve the precision and availability of diagnostic imaging for intricate medical conditions. These advanced radiopharmaceutical imaging agents are specialized compounds that contain radioactive labels, enabling medical professionals to visualize internal bodily structures via imaging methods. An example is Serac Healthcare Limited, a UK-based clinical radiopharmaceutical company, which in June 2024, secured Fast Track Designation from the US Food and Drug Administration (FDA) for 99mTc-maraciclatide. This is a pioneering single-photon emission computed tomography (SPECT)-computed tomography (CT) imaging agent intended for visualizing and diagnosing superficial peritoneal endometriosis in women aged 16 years and older. 99mTc-maraciclatide is a technetium-99m-labeled targeted peptide imaging agent designed to attach to integrins that are overexpressed in endometriosis lesions, thus allowing distinct visualization of affected areas during SPECT-CT scans. This agent presents a non-invasive diagnostic alternative to laparoscopic procedures, offering women with suspected endometriosis a safer and more readily available diagnostic route. It utilizes the advantageous imaging characteristics of technetium-99m, such as its optimal half-life and gamma emission energy, to produce high-quality diagnostic images while reducing patient radiation exposure. This advancement is expected to boost diagnostic precision and simplify treatment choices in endometriosis management, concurrently broadening the clinical uses of technetium-99m-based imaging within women’s health.
Which Major Players Dominate The Technetium-99m Market?
Major companies operating in the technetium-99m market are Cardinal Health Inc, GE Healthcare Technologies Inc, BWX Technologies Inc, Bracco Imaging S p A, Lantheus Holdings Inc, China Isotope And Radiation Corporation, Jubilant Pharma Limited, Curium Pharma LLC, Eckert And Ziegler Strahlen, NorthStar Medical Radioisotopes LLC, NTP Radioisotopes SOC Ltd, Isotopia Molecular Imaging Ltd, Cyclopharm Limited, SHINE Technologies LLC, Medi Radiopharma Kft, SDS Lifesciences Pvt Ltd, ANSTO Nuclear Medicine, IRE ELiT, Sam Young Unitech Co Ltd, RadioMedix Inc, Institute Of Isotopes Co Ltd, Monrol Nuclear Products
Read the full technetium-99m market report here:
https://www.thebusinessresearchcompany.com/report/technetium-99m-global-market-report
Which Region Currently Holds The Largest Share Of The Technetium-99m Market?
North America was the largest region in the technetium-99m market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the technetium-99m market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Tailored Technetium-99m Market Research Report For Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=25920&type=smp
Browse Through More Reports Similar to the Global Technetium-99m Market 2026, By The Business Research Company
5G Ntn Market Report 2026
https://www.thebusinessresearchcompany.com/report/5g-ntn-global-market-report
Adtech Market Report 2026
https://www.thebusinessresearchcompany.com/report/adtech-global-market-report
Regtech Market 2026
https://www.thebusinessresearchcompany.com/report/regtech-market
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model